Ocriplasmin holds promise, but indications need to be clarified

COPENHAGEN, Denmark — Results of the MIVI-TRUST studies have shown that ocriplasmin effectively induces posterior vitreous detachment in cases of abnormal vitreomacular adhesion, but indications still have to be clarified, according to a specialist.Vitreomacular adhesion can lead to a range of sequelae, including vitreomacular traction and macular hole, and is linked to retinal pathologies such as wet age-related macular degeneration, diabetic macular edema and retinal vein occlusion.

Full Story →